![]() |
||||||
![]() |
FOCUSED ULTRASOUND SURGERY FOUNDATION |
NEWSLETTER VOL. 24 | ||||
|
![]() |
||
![]() |
Dear Subscriber A unique gathering point for the MR-guided focused ultrasound community, the symposium will spotlight key advances in patient treatments as well as ground-breaking research. It will provide ample opportunity for attendees to share information, to develop and expand collaborations, and to identify new research possibilities. On the clinical side, symposium presenters will discuss the latest patient data for investigational treatments; these range from prostate, breast and liver cancer to functional brain disorders and to facet rhizotomy for lower back pain. On the research side, presenters will report ground-breaking results for blood-brain barrier disruption, ischemic stroke, stem cell activation, and Benign Prostatic Hyperplasia (BPH) and for pancreatic and liver cancer. Other important developments to be covered include bone tumors, uterine fibroids, targeted drug delivery and various aspects of MR-guided focused ultrasound technology. |
![]() |
|||
Final symposium program posted online | |||
![]() |
|
![]() |
|
![]() |
![]() |
|||
FDA lab director, Steven Pollack, Ph.D., will be special lecturer | |||
![]() |
|
![]() |
|
![]() |
![]() |
|||
Discussion groups will address topics requested by FUS community | |||
![]() |
|
![]() |
|
![]() |
![]() |
|||
Foundation announces 2010 Young Investigator Award recipients | |||
![]() |
|
![]() |
|
![]() |
![]() |
|||
Mayo Clinic uterine fibroid survey set for symposium | |||
![]() |
|
![]() |
|
![]() |
![]() |
|||
Exhibit Hall will open Monday, Oct. 18 | |||
![]() |
|
![]() |
|
![]() |
![]() |
![]() |